Ameriprise’s abrdn Healthcare Investors HQH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.3M Buy
466,695
+10,646
+2% +$201K ﹤0.01% 2061
2025
Q4
$8.64M Buy
456,049
+44,111
+11% +$833K ﹤0.01% 2026
2025
Q3
$7.62M Buy
411,938
+64,868
+19% +$1.06M ﹤0.01% 2114
2025
Q2
$5.37M Buy
347,070
+24,492
+8% +$379K ﹤0.01% 2306
2025
Q1
$5.24M Buy
322,578
+34,971
+12% +$601K ﹤0.01% 2276
2024
Q4
$4.62M Buy
287,607
+27,043
+10% +$480K ﹤0.01% 2415
2024
Q3
$4.85M Sell
260,564
-14,031
-5% -$261K ﹤0.01% 2395
2024
Q2
$4.79M Buy
274,595
+172,110
+168% +$2.87M ﹤0.01% 2348
2024
Q1
$1.73M Sell
102,485
-6,177
-6% -$105K ﹤0.01% 2941
2023
Q4
$1.8M Sell
108,662
-6,455
-6% -$99.2K ﹤0.01% 2923
2023
Q3
$1.79M Sell
115,117
-25,155
-18% -$420K ﹤0.01% 2872
2023
Q2
$2.39M Buy
140,272
+21,124
+18% +$366K ﹤0.01% 2794
2023
Q1
$2.1M Buy
119,148
+6,022
+5% +$110K ﹤0.01% 2826
2022
Q4
$2.1M Buy
113,126
+1,346
+1% +$24.9K ﹤0.01% 2786
2022
Q3
$1.93M Sell
111,780
-32,025
-22% -$612K ﹤0.01% 2800
2022
Q2
$2.69M Buy
143,805
+7,623
+6% +$151K ﹤0.01% 2689
2022
Q1
$2.83M Buy
136,182
+18,660
+16% +$396K ﹤0.01% 2760
2021
Q4
$2.79M Buy
117,522
+6,713
+6% +$167K ﹤0.01% 2824
2021
Q3
$2.84M Sell
110,809
-13,281
-11% -$349K ﹤0.01% 2720
2021
Q2
$3.19M Sell
124,090
-4,231
-3% -$104K ﹤0.01% 2716
2021
Q1
$3.13M Buy
128,321
+32,371
+34% +$789K ﹤0.01% 2665
2020
Q4
$2.29M Buy
95,950
+23,837
+33% +$518K ﹤0.01% 2722
2020
Q3
$1.49M Buy
72,113
+41,434
+135% +$876K ﹤0.01% 2808
2020
Q2
$654K Sell
30,679
-102
-0.3% -$2.08K ﹤0.01% 3092
2020
Q1
$548K Sell
30,781
-2,527
-8% -$49.8K ﹤0.01% 3085
2019
Q4
$696K Sell
33,308
-3,132
-9% -$62K ﹤0.01% 3219
2019
Q3
$668K Sell
36,440
-176
-0.5% -$3.39K ﹤0.01% 3192
2019
Q2
$737K Buy
36,616
+176
+0.5% +$3.48K ﹤0.01% 3183
2019
Q1
$758K Buy
36,440
+1,405
+4% +$28.8K ﹤0.01% 3147
2018
Q4
$634K Sell
35,035
-1,432
-4% -$29.3K ﹤0.01% 3119
2018
Q3
$844K Buy
36,467
+5,028
+16% +$114K ﹤0.01% 3131
2018
Q2
$676K Sell
31,439
-1,658
-5% -$35.3K ﹤0.01% 3150
2018
Q1
$713K Buy
33,097
+2,191
+7% +$50.4K ﹤0.01% 3104
2017
Q4
$703K Buy
30,906
+1,333
+5% +$31.2K ﹤0.01% 3111
2017
Q3
$746K Buy
29,573
+1,100
+4% +$27.6K ﹤0.01% 3079
2017
Q2
$715K Sell
28,473
-170
-0.6% -$4.21K ﹤0.01% 3092
2017
Q1
$689K Buy
28,643
+2,423
+9% +$56.9K ﹤0.01% 3064
2016
Q4
$554K Buy
26,220
+1,738
+7% +$38.7K ﹤0.01% 3234
2016
Q3
$583K Buy
24,482
+3,387
+16% +$85.2K ﹤0.01% 3122
2016
Q2
$494K Sell
21,095
-107
-0.5% -$2.65K ﹤0.01% 3170
2016
Q1
$509K Buy
21,202
+1,337
+7% +$31.8K ﹤0.01% 3159
2015
Q4
$589K Buy
19,865
+2,597
+15% +$80.2K ﹤0.01% 3186
2015
Q3
$477K Buy
17,268
+3,152
+22% +$107K ﹤0.01% 3288
2015
Q2
$491K Buy
14,116
+1,222
+9% +$42.4K ﹤0.01% 3453
2015
Q1
$439K Buy
12,894
+931
+8% +$31.2K ﹤0.01% 3262
2014
Q4
$368K Buy
11,963
+1,077
+10% +$32.4K ﹤0.01% 3246
2014
Q3
$302K Buy
10,886
+1,674
+18% +$45.4K ﹤0.01% 3220
2014
Q2
$237K Sell
9,212
-574
-6% -$15K ﹤0.01% 3247
2014
Q1
$260K Buy
9,786
+259
+3% +$7.2K ﹤0.01% 3154
2013
Q4
$252K Buy
9,527
+4,393
+86% +$108K ﹤0.01% 3064
2013
Q3
$120K Buy
5,134
+255
+5% +$6.02K ﹤0.01% 3382
2013
Q2
$110K Buy
+4,879
New +$104K ﹤0.01% 3338

Other funds holding HQH

Ameriprise's HQH Position: Q1 2026 in Review

Ameriprise increased its abrdn Healthcare Investors (HQH) stake by 2.3% in Q1 2026, buying an estimated $201K and bringing the position to 466,695 shares worth $8.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2061.

Ameriprise first reported a position in HQH in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.64M in Q4 2025. 128 funds tracked by Wall St. Rank hold HQH as of Q1 2026.

  • Ameriprise held 466,695 shares of abrdn Healthcare Investors worth $8.3M as of Q1 2026.
  • Ameriprise bought 10,646 abrdn Healthcare Investors shares in Q1 2026, an estimated $201K.
  • abrdn Healthcare Investors made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2061 holding.
  • Ameriprise first reported a position in abrdn Healthcare Investors in Q2 2013 and has held it in 52 quarters since.
  • Ameriprise's abrdn Healthcare Investors position peaked at $8.64M in Q4 2025.
  • 128 funds tracked by Wall St. Rank held abrdn Healthcare Investors as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.